Global Biosynthesis of Cannabinoids Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Biosynthesis of Cannabinoids Market Insights, Forecast to 2034
Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
Market Analysis and InsightsGlobal Biosynthesis of Cannabinoids Market
Global Biosynthesis of Cannabinoids market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biosynthesis of Cannabinoids industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Biosynthesis of Cannabinoids key companies include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Anandia Laboratories, Gingko Bioworks, Hyasynth Bio are top 3 players and held % share in total in 2023.
When considering the consumption regions, % revenue of Biosynthesis of Cannabinoids were sold to North America, Europe and Asia Pacific in 2023. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biosynthesis of Cannabinoids market and estimated to attract more attentions from industry insiders and investors.
Biosynthesis of Cannabinoids can be divided into THC, CBD and Others,, etc. THC is the mainstream product in the market, accounting for % revenue share globally in 2023 and the proportion will be % in 2033.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % revenue of Biosynthesis of Cannabinoids went into Food Industry filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biosynthesis of Cannabinoids market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others
Food Industry
Medical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biosynthesis of Cannabinoids introduction, etc. Biosynthesis of Cannabinoids Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Biosynthesis of Cannabinoids
Chapter 13Methodology and Data Sources adopted by MRA Research
Market Analysis and InsightsGlobal Biosynthesis of Cannabinoids Market
Global Biosynthesis of Cannabinoids market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biosynthesis of Cannabinoids industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Biosynthesis of Cannabinoids key companies include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Anandia Laboratories, Gingko Bioworks, Hyasynth Bio are top 3 players and held % share in total in 2023.
When considering the consumption regions, % revenue of Biosynthesis of Cannabinoids were sold to North America, Europe and Asia Pacific in 2023. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biosynthesis of Cannabinoids market and estimated to attract more attentions from industry insiders and investors.
Biosynthesis of Cannabinoids can be divided into THC, CBD and Others,, etc. THC is the mainstream product in the market, accounting for % revenue share globally in 2023 and the proportion will be % in 2033.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % revenue of Biosynthesis of Cannabinoids went into Food Industry filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biosynthesis of Cannabinoids market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others
Segment by Application
Food Industry
Medical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biosynthesis of Cannabinoids introduction, etc. Biosynthesis of Cannabinoids Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Biosynthesis of Cannabinoids
Chapter 13Methodology and Data Sources adopted by MRA Research